Synthesis and evaluation of S -4-(3-thienyl)phenyl-α-methylacetic acid

Mittal, Shilpi ; Malde, Alpeshkumar ; Selvam, C. ; Arun, K.H.S. ; Johar, P.S. ; Jachak, Sanjay M. ; Ramarao, P. ; Bharatam, P.V. ; Chawla, H.P.S. (2004) Synthesis and evaluation of S -4-(3-thienyl)phenyl-α-methylacetic acid Bioorganic & Medicinal Chemistry Letters, 14 (4). pp. 979-982. ISSN 0960-894X

Full text not available from this repository.

Official URL: http://doi.org/10.1016/j.bmcl.2003.11.066

Related URL: http://dx.doi.org/10.1016/j.bmcl.2003.11.066

Abstract

Herein we report an efficient procedure to synthesize S-4-(3-thienyl)phenyl-α-methylacetic acid, an enantiomerically pure intermediate of a recently approved nonsteroidal antiinflammatory cyclooxygenase inhibitor, atliprofen [methyl RS-4-(3-thienyl)phenyl-α-methylacetate]. The interactions of the active S-isomer of the acid were theoretically compared with those of S-ibuprofen through molecular docking studies using COX-1 and COX-2 protein structures. The results were corroborated by in vitro and in vivo studies. An efficient process for the preparation of S-4-(3-thienyl)phenyl-α-methylacetic acid, an enantiomerically pure intermediate of recently approved NSAID atliprofen is reported. The pharmacologically active isomer, S-4-(3-thienyl)phenyl-α-methylacetic acid was compared with S-ibuprofen by docking studies on COX enzyme structures followed by biological evaluations.

Item Type:Article
Source:Copyright of this article belongs to Elsevier B.V.
Keywords:Arylpropionic Acid; Docking; Cyclooxygenase.
ID Code:116674
Deposited On:12 Apr 2021 11:42
Last Modified:12 Apr 2021 11:42

Repository Staff Only: item control page